- $532.91m
- $546.97m
- $36.97m
Clearpoint Neuro Inc expected to post a loss of 18 cents a share - Earnings Preview
Brief: Clearpoint Neuro To Showcase Two Novel Innovations At Aans 2023
Brief: ClearPoint Neuro Announces Agreement With NE Scientific
Brief: ClearPoint Neuro Announces ANVISA Approval Of Neuro Navigation Portfolio In Brazil
Brief: Clearpoint Neuro Extends Software License And Research Agreement With Philips To Include Fully Automatic Subnuclei Segmentation For Dbs
Brief: Clearpoint Neuro Announces Exclusive Multi-Year Licensing Agreement With UCSF
Brief: Clearpoint Neuro Announces Multi-Year Licensing Agreement With UCSF
Brief: ClearPoint Neuro Reports Q4 Results
Clearpoint Neuro Inc reports results for the quarter ended in December - Earnings Summary
Clearpoint Neuro Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: ClearPoint Neuro Reports Q4 Revenue Of $5.2 Mln
Brief: ClearPoint Neuro Enrolls First Patient in Glioblastoma Trial Using Prism Neuro Laser Therapy System
Clearpoint Neuro Inc reports results for the quarter ended in September - Earnings Summary
Clearpoint Neuro Inc expected to post a loss of 19 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Costco, FedEx, Coinbase, Exxon
ClearPoint Neuro up on FDA clearance for partner's laser therapy system
Brief: Clearpoint Neuro Announces FDA Clearance For Clearpoint Prism Neuro Laser Therapy System
Brief: Clearpoint Neuro Announces FDA Clearance For Software Version 2.1
Clearpoint Neuro Inc reports results for the quarter ended in June - Earnings Summary